A U.S. cannabis company has made a bid to acquire Aurora Cannabis Inc., prompting the Edmonton-based firm to establish a special committee to assess the proposal. Curaleaf Holdings Inc. announced its intention to purchase all shares of Aurora, aiming to create a combined cannabis entity operating in 17 countries globally. Despite unsuccessful private negotiations with Aurora’s leadership, Curaleaf has now publicly disclosed its offer after receiving no engagement from Aurora following formal letters of intent on June 23 and July 7.
Curaleaf proposes to pay Aurora shareholders $4 US per share, along with an additional $0.75 US cash per share. However, Aurora refutes Curaleaf’s assertion that it declined to engage with the bid, citing ongoing correspondence between the companies’ executives. Aurora’s independent directors will convene a special committee to evaluate the offer’s viability and its implications for stakeholders, emphasizing that a deal is not guaranteed.
While acknowledging Curaleaf’s interest, Aurora cautions that the current offer undervalues its long-term potential. Analysts echoed this sentiment, stating that the proposed compensation fails to reflect Aurora’s market leadership, product portfolio, financial strength, and regulatory expertise. Curaleaf believes that merging the companies would enhance value through synergies and expanded global reach, anticipating significant revenue and cost benefits from the acquisition.
Curaleaf’s CEO expressed confidence in the proposed merger, highlighting the opportunity for Aurora shareholders to participate in a more diversified global platform and leverage U.S. regulatory trends. Both companies have collectively generated over $1.5 billion US in revenue in the past year, with Curaleaf expecting substantial annual cost savings from the potential deal.